Stocks
Sarepta Therapeutics, Inc.SRPT
NASDAQHealthcareBiotechnology$16.40-3.76%
Focused on genetic medicine, the company develops therapies for rare neuromuscular diseases, with a primary emphasis on treatments for Duchenne muscular dystrophy. Its portfolio includes approved exon-skipping therapies and a developing pipeline of gene therapies targeting underlying genetic mutatio...
Market Cap: $1.7B52W Range: $10.42 – $103.32
Congressional Interest in Sarepta Therapeutics, Inc. (SRPT)
6 members of Congress have disclosed 22 trades in Sarepta Therapeutics, Inc. (SRPT), a Healthcare company. The buy/sell breakdown shows 13 purchases versus 9 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
22
Unique Politicians
6
Buys
13
Sells
9
Who in Congress Is Trading SRPT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-04-14 | Gilbert Cisneros | sell | $1K – $15K |
| 2024-11-19 | MICHAEL T. MCCAUL | sell | $1K – $15K |